Delivery of efficacious, safe and differentiated preclinical candidates is based on extensive experience in chemistry, pharmacology, ADME, pharmacokinetics and toxicology.
Producing high quality compounds for your project through profound understanding of medicinal chemistry, custom synthesis and analysis
Assessing the efficacy and safety of your compounds based on tight integration of various in vitro assays, in vivo models and toxicology
Providing high quality data to aid the progression of compounds with the best chance of success through a comprehensive range of in vitro ADME, in vivo pharmacokinetic and bioanalytical services
Ideal starting point or entirely new direction for your drug discovery through Fidelta’s unique macrolide inspired macrocyclic library

Welcome to Fidelta

Excellence in integrated drug discovery services

Are you looking for the partner who can take your project from target to preclinical development?
Fidelta has the necessary set up and expertise for fully integrated drug discovery, backed up by a successful delivery track record.
Our goal is to provide efficacious, safe and differentiated preclinical candidates. We place strong emphasis on translational science, focusing on disease relevant animal models and ex-vivo studies where appropriate from patient samples, with the discovery process driven by expert medicinal chemistry and ADME/PK.
Inflammation and infection are our core expertise, accompanied by experience in additional therapeutic areas.
Macrocyclic chemistry is a particular forte of Fidelta.

Integrated drug discovery is what we do best

Entrust your project to us and gain access to our extensive experience in pharma R&D, our scientific expertise and outstanding capabilities covering the entire drug discovery process – At Fidelta, we are driven to provide high quality drug discovery services and solutions to our clients.

Excellence in providing individual services and service packages

Choose from a range of stand-alone services or let us customize a service package to meet your specific needs in drug discovery.

In addition to our standard list of services and assays we offer customized assay development and validation, both in vitro and in vivo, upon request.

Building long term relationships is important

Strong believers in building long-term relationships with our clients, we pride ourselves in working through close communication with our clients, flexibility, problem solving orientation and delivery within agreed timelines.

Fidelta video

News More...

Selvita to acquire Fidelta from Galapagos
  - Strengthening Selvita’s position as one of the largest preclinical contract research organizations in Europe - Acquisition substantially expands Selvita’s integrated drug discovery services offering Transaction will almost double Selvita’s revenues Enterprise value of € 31.2M  to be paid in cash Fidelta to continue performing drug discovery services for Galapagos for the next five…
Fidelta announces drug discovery agreement with Galapagos
12th December 2018 Fidelta announces drug discovery agreement with Galapagos Zagreb, Croatia, 12th – Fidelta Ltd is pleased to announce that it has signed an integrated drug discovery agreement with Galapagos based on Fidelta’s macrocyclic platform. Under the terms of the agreement, Galapagos will leverage Fidelta’s extensive expertise in macrocyclic drug discovery to further strengthen…
World Preclinical Congress
The World Preclinical Congress will take place in Lisbon on 27th-30th of November 2018. The event is driven by the willingness to bring together scientists from pharma/biotech companies and academia with a particular focus on highlighting the various challenges and opportunities that exist in early drug discovery. Fidelta is very excited to take an active…
Around the macrolide – Impact of 3D structure of macrocycles on lipophilicity and cellular accumulation
Maybe you would be interested to check our recently published article. It has been waiting for years to be published and we are happy it finally is! The article is available for free download for the next 6 weeks on
Mirjana Bukvic named the 2017 Young Medicinal Chemist in Industry
Congratulations to our very own Mirjana Bukvic for being named the 2017 Young Medicinal Chemist in Industry by the European Federation for Medicinal Chemistry!

Events More...

Fidelta will be attending the 3rd International Conference on Tissue Repair, regeneration and fibrosis, 06 – 11 October, Kos, Greece
Open Event
Fidelta will be attending 3rd SCI / RSC Symposium on Antimicrobial Drug Discovery, 16 – 17 November, London, UK
Open Event